Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Stancliff

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
American Family Physician|March 17, 2011
Injection drug users can be effectively treated for hepatitis CSharon Stancliff
Journal of Substance Abuse Treatment|February 20, 2007
Regarding naltrexone for probationers and paroleesSharon Stancliff
JAMA|November 27, 2008
Syringe access and HIV incidence in the United StatesSharon Stancliff
Mayo Clinic Proceedings|August 7, 2012
Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversyJeffrey Selzer, Sharon Stancliff
Public Health Reports (Washington, D.C. : 1974)|May 24, 2007
Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York CityDaliah I Heller, Sharon Stancliff
JAMA|July 17, 2019
Cannabis as a Substitute for OpioidsCharles John Gonzalez, Nicole Quackenbush, Sharon Stancliff
American Journal of Public Health|November 7, 2019
Why 24 State and Territorial Health Officials Support Buprenorphine DeregulationSharon Stancliff, Danielle Greene, Howard A Zucker
The American Journal of Medicine|October 26, 2013
The replyR Douglas Bruce, Leo Beletsky, Sharon Stancliff
Journal of Addictive Diseases|June 17, 2015
Harm Reduction: Front Line Public HealthSharon Stancliff, Benjamin W Phillips, Nazlee Maghsoudi, et al.
BMC Public Health|November 25, 2003
Syringe access for the prevention of blood borne infections among injection drug usersSharon Stancliff, Bruce Agins, Josiah D Rich, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
American Family Physician|March 17, 2011
Injection drug users can be effectively treated for hepatitis CSharon Stancliff
Journal of Substance Abuse Treatment|February 20, 2007
Regarding naltrexone for probationers and paroleesSharon Stancliff
JAMA|November 27, 2008
Syringe access and HIV incidence in the United StatesSharon Stancliff
Mayo Clinic Proceedings|August 7, 2012
Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversyJeffrey Selzer, Sharon Stancliff
Public Health Reports (Washington, D.C. : 1974)|May 24, 2007
Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York CityDaliah I Heller, Sharon Stancliff
JAMA|July 17, 2019
Cannabis as a Substitute for OpioidsCharles John Gonzalez, Nicole Quackenbush, Sharon Stancliff
American Journal of Public Health|November 7, 2019
Why 24 State and Territorial Health Officials Support Buprenorphine DeregulationSharon Stancliff, Danielle Greene, Howard A Zucker
The American Journal of Medicine|October 26, 2013
The replyR Douglas Bruce, Leo Beletsky, Sharon Stancliff
Journal of Addictive Diseases|June 17, 2015
Harm Reduction: Front Line Public HealthSharon Stancliff, Benjamin W Phillips, Nazlee Maghsoudi, et al.
BMC Public Health|November 25, 2003
Syringe access for the prevention of blood borne infections among injection drug usersSharon Stancliff, Bruce Agins, Josiah D Rich, et al.
Pageof 3